Jubilant Pharmova Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Bonus
• Share holding
• Capital structures
• Ratio

Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20	Mar ' 19

Sources of funds

Owner's fund

Equity share capital

15.93

15.93

15.93

15.93

15.93

Share application money

-

-

-

-

-

Preference share capital

-

-

-

-

-

Reserves & surplus

2,398.62

1,265.89

1,266.52

2,591.37

2,324.38

Loan funds

Secured loans

301.50

499.00

493.00

1,950.89

1,602.29

Unsecured loans

-

-

-

-

-

Total

2,716.05

1,780.82

1,775.45

4,558.18

3,942.60

Uses of funds

Fixed assets

Gross block

946.47

148.21

148.93

2,277.53

1,812.70

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

259.07

24.67

21.85

412.81

321.34

Net block

687.40

123.54

127.08

1,864.72

1,491.35

Capital work-in-progress

46.97

0.06

0.33

59.09

283.82

Investments

1,656.57

1,645.75

1,645.98

1,764.03

1,763.89

Net current assets

Current assets, loans & advances

617.54

60.12

71.20

1,745.55

1,324.56

Less : current liabilities & provisions

292.42

48.65

69.15

875.21

921.03

Total net current assets

325.12

11.47

2.05

870.34

403.53

Miscellaneous expenses not written

-

-

-

-

-

Total

2,716.05

1,780.82

1,775.45

4,558.18

3,942.60

Notes:

Book value of unquoted investments

1,656.57

1,645.75

1,645.98

1,764.03

1,763.89

Market value of quoted investments

-

-

-

-

-

Contingent liabilities

116.26

69.70

70.39

478.39

678.83

Number of equity sharesoutstanding (Lacs)

1592.81

1592.81

1592.81

1592.81

1592.81